M&A Deal Summary

Altruix Acquires Ganse Apothecary

On July 14, 2022, Altruix acquired life science company Ganse Apothecary

Acquisition Highlights
  • This is Altruix’s 1st transaction in the Life Science sector.
  • This is Altruix’s 1st transaction in the United States.
  • This is Altruix’s 1st transaction in Pennsylvania.

M&A Deal Summary
Date 2022-07-14
Target Ganse Apothecary
Sector Life Science
Buyer(s) Altruix
Deal Type Merger
Advisor(s) Provident (Financial)
Troutman Pepper Hamilton Sanders (Legal)

Target

Ganse Apothecary

Lancaster, Pennsylvania, United States
Ganse Apothecary is a URAC accredited specialty, long-term care, and retail pharmacy that provides pharmacy services to individuals with serious and persistent mental illness, substance use disorders, and intellectual and developmental disabilities, the organizations that support them, and to the general public as well. Ganse Apothecary is based in Lancaster, Pennsylvania.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Altruix

Annapolis, Maryland, United States
Category Company
Sector Life Science
DESCRIPTION

Altruix is a closed-door specialized pharmacy that primarily serves individuals diagnosed with severe and persistent mental illnesses in the Mid-Atlantic region. The Company serves this population through high-touch distribution relationships with community-based behavioral health agencies and long-term care facilities, enabling improved medication adherence and care management for complex and costly patient populations. Altruix is based in Annapolis, Maryland.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Merger) 1 of 1
State (Pennsylvania) 1 of 1
Country (United States) 1 of 1
Year (2022) 1 of 1
Mergr

Product

Company

Legal